PMID- 19705213 OWN - NLM STAT- MEDLINE DCOM- 20100324 LR - 20211020 IS - 1476-3524 (Electronic) IS - 1029-8428 (Linking) VI - 17 IP - 3 DP - 2010 Apr TI - Depressive-like parameters in sepsis survivor rats. PG - 279-86 LID - 10.1007/s12640-009-9101-6 [doi] AB - The inflammatory and immune responses evoked in sepsis may create not only an acute brain dysfunction, which occurs in the majority of septic patients, but also long-term deficits such as memory impairment. In this context, we evaluated depressive-like parameters in sepsis survivor rats. For this purpose, male Wistar rats, weighing 300-350 g, underwent cecal ligation and perforation (CLP) (sepsis group) followed by "basic support", or were sham-operated (control group). After 3 days of the sepsis procedure, the animals were treated with imipramine at 10 mg/kg or saline during 14 days (days 3-17). The consumption of sweet food was measured for 7 days (days 10-17) and the body weight was measured before CLP, 10, and 17 days after CLP. Seventeen days after sepsis (immediately after sweet food consumption measurement), the animals were anesthetized and blood was withdrawn for the analyses of corticosterone and adrenocorticotropic hormone (ACTH) levels, and immediately killed by decapitation. The adrenal gland and hippocampus were immediately isolated and weighed, and the hippocampus was utilized for determining brain-derived neurotrophic factor (BDNF) levels. It was observed that animals subjected to CLP presented decreased sucrose intake. Septic rats did not increase body weight and presented an increase in the weight of adrenal gland. Both corticosterone and ACTH levels were increased, while hippocampus weight and BDNF levels in the hippocampus decreased. The treatment with imipramine reversed all the parameters described above. Our results supported the hypothesis that rats that survive sepsis show depressive-like behavior, alterations in the hypothalamus-pituitary-adrenal axis, and decreased BDNF levels in the hippocampus. FAU - Comim, Clarissa M AU - Comim CM AD - Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. FAU - Cassol, Omar J Jr AU - Cassol OJ Jr FAU - Constantino, Leandra C AU - Constantino LC FAU - Petronilho, Fabricia AU - Petronilho F FAU - Constantino, Larissa S AU - Constantino LS FAU - Stertz, Laura AU - Stertz L FAU - Kapczinski, Flavio AU - Kapczinski F FAU - Barichello, Tatiana AU - Barichello T FAU - Quevedo, Joao AU - Quevedo J FAU - Dal-Pizzol, Felipe AU - Dal-Pizzol F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090825 PL - United States TA - Neurotox Res JT - Neurotoxicity research JID - 100929017 RN - 0 (Antidepressive Agents, Tricyclic) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 9002-60-2 (Adrenocorticotropic Hormone) RN - OGG85SX4E4 (Imipramine) RN - W980KJ009P (Corticosterone) SB - IM MH - Adrenal Glands/drug effects MH - Adrenocorticotropic Hormone/blood MH - Analysis of Variance MH - Animals MH - Antidepressive Agents, Tricyclic/*therapeutic use MH - Body Weight/drug effects MH - Brain-Derived Neurotrophic Factor/metabolism MH - Corticosterone/blood MH - Depression/drug therapy/*etiology/pathology MH - Disease Models, Animal MH - Food Preferences/drug effects MH - Hippocampus/drug effects/metabolism/pathology MH - Imipramine/pharmacology/*therapeutic use MH - Male MH - Organ Size/drug effects MH - Rats MH - Rats, Wistar MH - Sepsis/*complications EDAT- 2009/08/26 09:00 MHDA- 2010/03/25 06:00 CRDT- 2009/08/26 09:00 PHST- 2009/03/23 00:00 [received] PHST- 2009/08/13 00:00 [accepted] PHST- 2009/07/25 00:00 [revised] PHST- 2009/08/26 09:00 [entrez] PHST- 2009/08/26 09:00 [pubmed] PHST- 2010/03/25 06:00 [medline] AID - 10.1007/s12640-009-9101-6 [doi] PST - ppublish SO - Neurotox Res. 2010 Apr;17(3):279-86. doi: 10.1007/s12640-009-9101-6. Epub 2009 Aug 25.